341 related articles for article (PubMed ID: 6163639)
1. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
2. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
4. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
6. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
7. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta-induced reduction of superoxide anion generation by macrophages.
Boraschi D; Ghezzi P; Salmona M; Tagliabue A
Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
[TBL] [Abstract][Full Text] [Related]
9. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
Boraschi D; Niederhuber JE
J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
Paulnock DM; Lambert LE
J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
[TBL] [Abstract][Full Text] [Related]
13. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
15. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
16. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
17. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
Ruco LP; Meltzer MS
J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-induced suppression of macrophage-mediated tumoricidal activity in murine macrophages.
Koff WC; Dunegan MA; Chakrabarty MK; Hampar B; Showalter SD
Cancer Res; 1987 Mar; 47(6):1534-7. PubMed ID: 2434219
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.
Pace JL; Russell SW; LeBlanc PA; Murasko DM
J Immunol; 1985 Feb; 134(2):977-81. PubMed ID: 2578167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]